WHO ICTRP trial
To Evaluate the Effects of Ashwagandha capsule on Skin and Hair Health in…
CTRI/2022/09/045770 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/09/045770 |
|---|---|
| Public title | To Evaluate the Effects of Ashwagandha capsule on Skin and Hair Health in Healthy adults |
| Scientific title | A Prospective, Randomized, Double-Blind, Placebo Controlled Clinical Study to Evaluate the Effects of KSM-66 Ashwagandha® capsule (300 mg) on Skin and Hair Health in Healthy Men and Women |
| Primary sponsor | Ixoreal Biomed Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Interventions | Intervention1: KSM-66 capsules containing Ashwagandha 300 mg standardized root extract: Standardized root extract 300 mg to be taken two times in a day orally with water/milk for period of 12 weeks Control Intervention1: Placebo Capsule… |
| Registration date | Sep 22, 2022 |
| Target size | 92 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: